title: p11 regulates extracellular plasmin production and invasiveness of HT1080 fibrosarcoma cells.
abstract: The defining characteristic of a tumor cell is its ability to escape the constraints imposed by neighboring cells, invade the surrounding tissue, and metastasize to distant sites. This invasive property of tumor cells is dependent on activation of proteases at the cell surface. Most cancer cells secrete the urokinase-type plasminogen activator, which converts cell-bound plasminogen to plasmin. Here we address the issue of whether the plasminogen binding protein, p11, plays a significant role in this process. Transfection of human HT1080 fibrosarcoma cells with the human p11 gene in the antisense orientation resulted in a loss of p11 protein from the cell surface and concomitant decreases in cellular plasmin production, ECM degradation, and cellular invasiveness. The transfected cells demonstrated reduced development of lung metastatic foci in SCID mice. In contrast, HT1080 cells transfected with the p11 gene in the sense orientation displayed increased cell surface p11 protein and concomitant increases in cellular plasmin production, as well as enhanced ECM degradation and enhanced cellular invasiveness. The p11 overexpressing cells showed enhanced development of lung metastatic foci. These data establish that changes in the extracellular expression of the plasminogen receptor protein, p11, dramatically affect tumor cell-mediated pericellular proteolysis.
authors.affiliation: Cancer Biology Research Group, Department of Medical Science, University of Calgary Calgary, Alberta, Canada T2N4N1.
authors.forename: Kyu-Sil
authors.initials: KS
authors.lastname: Choi
authors.forename: Darin K
authors.initials: DK
authors.lastname: Fogg
authors.forename: Chang-Soon
authors.initials: CS
authors.lastname: Yoon
authors.forename: David M
authors.initials: DM
authors.lastname: Waisman
mesh_terms: D000818:Animals; D017306:Annexin A2; D002135:Calcium-Binding Proteins / Q000235:genetics / Q000502:physiology*; D002460:Cell Line; D002465:Cell Movement / Q000187:drug effects; D005110:Extracellular Space / Q000378:metabolism; D005341:Fibrinolysin / Q000096:biosynthesis*; D005354:Fibrosarcoma / Q000378:metabolism* / Q000473:pathology; D005822:Genetic Vectors / Q000235:genetics; D006801:Humans; D008856:Microscopy, Fluorescence; D009361:Neoplasm Invasiveness; D010960:Plasminogen Activators / Q000378:metabolism; D012190:Retroviridae / Q000235:genetics; D009418:S100 Proteins; D014162:Transfection; D014407:Tumor Cells, Cultured / Q000187:drug effects; D000099248:S100 Calcium Binding Protein A10
chemical_list: D017306:Annexin A2; D002135:Calcium-Binding Proteins; D005341:Fibrinolysin; D010960:Plasminogen Activators; D009418:S100 Proteins; D000099248:S100 Calcium Binding Protein A10